Physicians Brace for Drug, Device 'Transparency'
Prior efforts to increase disclosure of industry-physicians financial relationship include a 2009 Institute of Medicine report, that developed recommendations "to identify, limit and manage without affecting constructive collaborations with industry and called for broad public transparency," according to the NEJE report.
The Physician Payment Sunshine Act was created by Congress to ensure transparency in physicians' interactions with the pharmaceutical, biologic and medical device industries as well as group purchasing organizations.
The law covers meals, honoraria, travel expenses, and grants from manufacturers, and ownership and investment interests by physicians or members of their immediate family. Eventually, physicians who have received payments or hold ownership will be posted on a website, under the National Physician Payment Transparency Program of the CMS.
The AMA is offering doctors a Physician Sunshine Act Tool Kit to help navigate the changes.
Joe Cantlupe is a senior editor with HealthLeaders Media Online.
- As Medicare Advantage Cuts Loom, Disagreement Over Program's Stability
- Doctors Feel Pressure to Accept Risk-based Reimbursement
- Surgical Checklists Unused in 10% of Hospitals, CMS Data Shows
- Centralizing the Revenue Cycle Protects the Bottom Line
- A Fresh Look at End-of-Life Care
- 3 in 4 Patients Want E-mail Consultations
- Heart Attack Patient Costs Skyrocket Beyond 30 Days
- ACGME Chief Sees 'Huge' Risk of Error in Proposed Assistant Physician Licensure
- CA Fines 8 Hospitals for Medical Errors
- 3 Insider Tips on Cutting Costs without Strangling Growth